Vincent Perrone | Senior Director of IR |
Liz Barrett | President and CEO |
Mark Schoenberg | Chief Medical Officer |
Jeff Bova | Chief Commercial Officer |
Don Kim | CFO |
Ram Selvaraju | H.C. Wainwright |
Boris Peaker | Cowen |
Chris Howerton | Jefferies |
Matt Kaplan | Ladenburg Thalmann |
Leland Gershell | Oppenheimer |
Anita Dushyanth | Berenberg Capital |
Good morning, ladies and gentlemen. Thank you for standing by, and welcome to UroGen Pharma's First Quarter 2022 Financial Results and Business Update Conference Call. It is now my pleasure to turn the call over to Vincent Perrone, Senior Director of Investor Relations for UroGen Pharma. Please go ahead.
Thank you, operator.